DVN vs VIR · P/E 7.4, rev $7.42B vs rev $238.9M
Devon Energy Corporation (DVN) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
DVN currently screens at market cap $22.42B and trailing P/E 7.4. VIR currently screens at market cap $1.45B.
Not investment advice. Open the DVN and VIR stock pages for the full models.
Not investment advice.